XML 36 R24.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Marketable Debt and Equity Securities (Tables)
6 Months Ended
Jun. 30, 2024
Marketable Securities [Abstract]  
Schedule of Marketable Securities
The Company’s marketable debt securities held as of June 30, 2024 and December 31, 2023 are summarized below:
June 30, 2024Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(in thousands)
Money Market Funds $11,624 $— $— $11,624 
Corporate Securities211,930 (279)211,657 
Government Securities342,945 (374)342,577 
$566,499 $12 $(653)$565,858 
Reported as
Cash and cash equivalents$11,624 
Marketable securities554,234 
Total investments$565,858 
December 31, 2023Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
(in thousands)
Money Market Funds $25,520 $— $— $25,520 
Corporate Securities228,382 342 (1)228,723 
Government Securities413,553 1,037 (76)414,514 
$667,455 $1,379 $(77)$668,757 
Reported as
Cash and cash equivalents$25,520 
Marketable securities643,237 
Total investments$668,757 
Schedule of Maturities of Marketable Securities
The maturities of the Company’s marketable debt securities as of June 30, 2024 are as follows:
June 30, 2024Amortized
Cost
Estimated
Fair Value
(in thousands)
Mature in one year or less$449,715 $449,372 
Mature within two years105,160 104,862 
$554,875 $554,234 
Schedule of Unrealized Losses on Available-for-Sale Investments
The unrealized losses on available-for-sale investments and their related fair values as of June 30, 2024 and December 31, 2023 are as follows:
Less than 12 months12 months or greater
June 30, 2024Fair valueUnrealized
losses
Fair valueUnrealized
losses
(in thousands)
Corporate Securities$119,044 $(217)$11,895 $(62)
Government Securities246,154 (132)79,478 (242)
$365,198 $(349)$91,373 $(304)
Less than 12 months12 months or greater
December 31, 2023Fair valueUnrealized
losses
Fair valueUnrealized
losses
(in thousands)
Corporate Securities$8,073 $(1)$— $— 
Government Securities66,546 (76)— — 
$74,619 $(77)$— $— 
Schedule of Equity Securities with Readily Determinable Fair Value Equity securities with a readily determinable fair value, which are categorized as Level 1 in the fair value hierarchy under ASC 820, and their fair values (in thousands) as of June 30, 2024 and December 31, 2023 are as follows:
Fair ValueFair Value
June 30, 2024December 31, 2023
Astria Common Stock$2,311 $5,360 
INmune Common Stock16,630 21,231 
Viridian Common Stock9,330 15,619 
$28,271 $42,210 
Schedule of Net Gains and Losses
Below is a reconciliation of net gain (loss) recorded on equity securities during the three and six months ended June 30, 2024 and 2023:
Three Months Ended
June 30,
Six Months Ended
June 30,
2024202320242023
Net gain (loss) recorded on equity securities
$(12,027)$288 $(9,702)$(2,610)
Less: Net gain (loss) recorded on sale of equity securities
(2,012)— 827 — 
Unrealized gain (loss) recorded on equity securities held at the reporting date
$(10,015)$288 $(10,529)$(2,610)
Schedule of Equity Securities Without Readily Determinable Fair Value Equity securities without a readily determinable fair value and their carrying values (in thousands) as of June 30, 2024 and December 31, 2023 are as follows:
Carrying ValueCarrying Value
June 30, 2024December 31, 2023
Zenas Preferred Stock$43,780 $64,210